Navigation Links
China Medical Technologies Completes the Development of EGFR Molecular Diagnostic Kits
Date:11/20/2008

BEIJING, Nov. 20 /PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that it has successfully completed the development of two proprietary molecular diagnostic kits for the detection of epidermal growth factor receptor ("EGFR") abnormalities in patients with non-small cell lung cancer ("NSCLC"). The Company expects to offer the kits to its hospital customers through its direct sales force in January 2009.

Currently, Iressa and Tarceva are commonly used drugs for the treatment of patients with NSCLC. These drugs target the EGFR gene located at 7p12. According to publications in medical journals, EGFR abnormalities have been found in approximately 85% of NSCLC patients responsive to Iressa and Tarceva. Some of these abnormalities could be identified by using FISH-based technique to detect increase in gene copy numbers; others could be detected by using real-time PCR-based technique to analyze EGFR gene mutations. The Company has successfully completed the development of both FISH and real-time PCR-based molecular diagnostic kits for detecting EGFR abnormalities. The test result provides guidance for physicians to determine the most appropriate therapy for patients with NSCLC.

"We are excited about the successful development of molecular diagnostic kits for non-small cell lung cancer therapy," said Mr. Xiaodong Wu, Chairman and CEO of the Company. "We will continue to leverage our molecular diagnostic technology platforms to develop more products with significant market potential."

Lung cancer is one of the most common cancers in the world and it is the leading cause of cancer death in China. It is estimated that more than 500,000
'/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. China Sky One Medical, Inc. Obtains Production Rights for Nine New Drugs
2. China Biologic Products Reports Strong Third Quarter 2008 Results
3. NYSE Alternext US Accepts China Shenghuos Compliance Plan for Continued Listing
4. China Medical Technologies Receives SFDA Approval for Breast Cancer HER-2 FISH Probe
5. China Biologic Products Announces Third Quarter 2008 Results Conference Call
6. China-Biotics, Inc. Reports Second Quarter 2009 Financial Results
7. China Clean Energy Resumes Biodiesel Production After Temporary Halt
8. China Medicine Announces Conference Call to Discuss Third Quarter 2008 Results
9. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
10. China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2008 Results
11. China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... VANCOUVER , Aug. 29, 2014 /PRNewswire/ - ... (OTCQX: ICOTF), today reported financial results for the ... specified otherwise, are expressed in Canadian dollars and ... Second Quarter 2014 Highlights , ... visual acuity (VA) primary endpoint for subjects enrolled ...
(Date:8/29/2014)... California (PRWEB) August 29, 2014 ... of Energy's 2014 Hydrogen Production R&D Award ... -- by splitting water using sunlight. , Shared ... (NREL) and the University of Nevada, Las Vegas ... work developing models of photoelectrochemical solar-hydrogen production and ...
(Date:8/29/2014)... Boston, MA (PRWEB) August 29, 2014 ... ones in the biotech start-up dense realm of Boston-Cambridge, ... alliances and able investors. James Sherley, the Director of ... made increasing the local and national visibility of his ... in September 2013. , In addition to a social ...
(Date:8/28/2014)... SPIE Fellow Glenn Boreman, Professor and ... and Director of the Center for Optoelectronics and Optical ... and co-founder and Chairman of the Board of Plasmonics, ... Vice President of SPIE, the international society for optics ... recent election results at the Annual General Meeting of ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Livermore Team Awarded for Hydrogen Production Research 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2
(Date:8/29/2014)... how the repeated climatic shifts over the last ... genetic diversity, a team of researchers led by ... Carnaval developed a new biodiversity metric called "phylogeographic ... the genetic variation within species is restricted in ... of biology, and 14 other researchers from institutions ...
(Date:8/29/2014)... such as the prolific bloomer Emiliania huxleyi , ... discovered. The finding contradicts the common view that ... on scarce supplies of thiamine in the ocean to ... about the ocean," says CIFAR Senior Fellow Alexandra ... paper with CIFAR fellows John Archibald (Dalhousie ...
(Date:8/28/2014)... Invasives is now available from the Lady Bird Johnson ... for identifying harmful non-native plant, insect and other invasive ... States cause about $137 billion in economic and other ... kill native plants and more. , "By having streamlined ... invasive species occur, we,re more likely to catch these ...
Breaking Biology News(10 mins):CCNY team defines new biodiversity metric 2Not all phytoplankton in the ocean need to take their vitamins 2Not all phytoplankton in the ocean need to take their vitamins 3Mobile app makes ID of harmful plants, insects in Texas a snap 2
... get their first solid food before 4 months of age ... developing Type 1 diabetes, University of Colorado researchers have found. ... and the CU School of Medicine,s Barbara Davis Center for ... mother is still breast-feeding the baby when solid foods, particularly ...
... N.J. -- The New Jersey Commission on Spinal Cord Injury ... grants, which exceed $1.2 million, fund studies of assisted walking ... spinal cord injury (SCI) and the effects of electrical stimulation ... the ability to advance research to find new treatments that ...
... -- Christopher Field, the founding director of Carnegie,s Department ... Germany,s most prestigious prizes, the Max Planck Research Prize ... knowledge of how life on Earth responds to climate ... biosphere and the atmosphere their work also helps us ...
Cached Biology News:Infants' food linked to higher, lower Type 1 diabetes risk 2Kessler Foundation awarded more than $1.2 million in grants by the NJ Commission on Sci Research 2Kessler Foundation awarded more than $1.2 million in grants by the NJ Commission on Sci Research 3Carnegie's Chris Field receives Max Planck Research Prize 2
Anti-LC3 Polyclonal Antibody Research Focus: cell surface antigens Storage: -20C Shipping Temperature: +4C...
...
... biological cells for DNA isolation. ... plates (includes 96 well plate adapters ... across the entire plate length (max ... Can be used for soil, microorganisms, ...
... Chicken polyclonal to LYZL6 ( ... Antigen: Synthetic ... DYKSYSENLC HVDCQD , corresponding to amino ... Entrez Gene ID: ...
Biology Products: